<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate whether endoscopic submucosal dissection (ESD) can be safely performed at small clinics, such as the Shirakawa Clinic </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: One thousand forty-seven ESDs to treat <z:e sem="disease" ids="C0017185" disease_type="Neoplastic Process" abbrv="">gastrointestinal tumors</z:e> were performed at the Shirakawa Clinic from April 2006 to March 2011 </plain></SENT>
<SENT sid="2" pm="."><plain>The efficacy, technical feasibility and associated complications of the procedures were assessed </plain></SENT>
<SENT sid="3" pm="."><plain>The ESD procedures were performed by five endoscopists </plain></SENT>
<SENT sid="4" pm="."><plain>Sedation was induced with <z:chebi fb="3" ids="44915">propofol</z:chebi> for esophagogastorduodenal ESD </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: One thousand forty-seven ESDs were performed to treat 64 patients with <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> (E), 850 patients with <z:e sem="disease" ids="C0038356" disease_type="Neoplastic Process" abbrv="">gastric tumors</z:e> (G: 764 patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, 82 patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> and four others), four patients with <z:e sem="disease" ids="C0541912" disease_type="Neoplastic Process" abbrv="">duodenal cancer</z:e> (D) and 129 patients with <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> (C: 94 patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, 21 patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 14 others) </plain></SENT>
<SENT sid="6" pm="."><plain>The en bloc resection rate was 94.3% (E: 96.9%, G: 95.8%, D: 100%, C: 79.8%) </plain></SENT>
<SENT sid="7" pm="."><plain>The median operation time was 46 min (range: 4-360 min) and the mean size of the resected specimens was 18 mm (range: 2-150 mm) </plain></SENT>
<SENT sid="8" pm="."><plain>No mortal complications were observed in association with the ESD procedures </plain></SENT>
<SENT sid="9" pm="."><plain><z:mpath ids='MPATH_81'>Perforation</z:mpath> occurred in 12 cases (1.1%, E: 1 case, G: 9 cases, D: 1 case, C: 1 case) and postoperative <z:mp ids='MP_0001914'>bleeding</z:mp> occurred in 53 cases (5.1%, G: 51 cases, D: 1 case, C: 1 case); however, no case required either emergency surgery or blood transfusion </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the <z:mpath ids='MPATH_81'>perforations</z:mpath> and postperative <z:mp ids='MP_0001914'>bleedings</z:mp> were resolved by endoscopic clipping or hemostasis </plain></SENT>
<SENT sid="11" pm="."><plain>The other problematic complication observed was <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, which was treated with conservative therapy </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: ESD can be safely performed in a clinic with established therapeutic methods and medical services to address potential complications </plain></SENT>
</text></document>